KRISTIN RAND: Open Payments
NPI 1033463674 · ERIE, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,876 in 89 payments from 12 companies in 2025. Trend: 2023 $2,563 · 2024 $2,564 · 2025 $1,876
Food & beverage: $1,876
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 21 | $557 |
| Amgen Inc. | 16 | $349 |
| ABBVIE INC. | 23 | $287 |
| UCB, Inc. | 10 | $264 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $99 |
| AstraZeneca Pharmaceuticals LP | 2 | $97 |
| Novartis Pharmaceuticals Corporation | 3 | $55 |
| E.R. Squibb & Sons, L.L.C. | 2 | $46 |
| GlaxoSmithKline, LLC. | 3 | $45 |
| PFIZER INC. | 2 | $32 |
Products named: TREMFYA, Bimzelx, RINVOQ, ENBREL, OTEZLA, SAPHNELO, OFEV, SKYRIZI.
Industry payments across PA — which companies pay providers there.
